Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
5
×
editas medicine
5
×
life sciences
national
5
×
national blog main
national top stories
biotech
boston blog main
cancer
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr therapeutics
deals
detroit blog main
detroit top stories
fda
ipo
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
crispr-cas9
eli lilly
europe blog main
indiana blog main
indiana top stories
What
bio
crispr
roundup
car
cas
ceo
gene
medicine
new
access
acquisitions
advanced
announced
bails
big
bosley's
bosley’s
brand
bridge
bridgebio
bucks
cancer
capacity
capital
cell
cells
collabs
consolidation
covid
crime
daniel
deal
defect
departure
develop
drive
drugs
editas
edited
editing
Language
unset
Current search:
crispr
×
national
×
" editas medicine "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells